Funny, Jim Cramer trying to cover their CNBC's short position before the Supreme Court decision in Delaware.
Now, there are 2 analyst price target increases in the last week. Price target increased to $7.25 / share for PIP. Buy from Aegis Capital with a price target of $7.00, and a more recent upgrade to Market Outperform and a price target increase to $8.00 / share.
Think about it, in the last few days, the price target of SIGA Technologies has been slashed in half, and the estimated revenue for this year and next has been cut by about 40 - 50 percent, while the revenue estimates for next year for PIP dropped only slightly based upon the earnings report. However, it appears that the results of the case decision has not truly been added to PIP's revenue estimates at all.
Should be great upside potential as a result of these stock manipulation attempts.
Could buy both SIGA and PIP for less than 0.25 billion, and have multiple drugs in the BioDefense area with great potential.
Price action in the last week or two indicate buyout may be imminent. With SIGA dropping its 2/25/2013 earnings date, it looks like the March 3- 8 to be the date of earnings, maybe near 3/13/2013 (PIP's earnings date) if SIGA plans to buy out PIP.
Things are getting interesting.... SIGA is obviously waiting on the outcome of the case before reporting earnings.